文献速递乳腺乳腺X线

人工智能对基于人群筛查项目中122969次乳腺X线检查的评估

Artificial Intelligence Evaluation of 122 969 Mammography Examinations from a Population-based Screening Program.
PubMed 文献 · Radiology · 2022-03-29

本回顾性研究纳入BreastScreen Norway四个筛查单元2009年10月至2018年12月的122969次乳腺X线检查,比较商用AI系统与常规独立双读加共识的性能,并分析不同AI评分肿瘤的病理特征。AI在三个阈值下未选中的筛查检出癌比例均低于20%,总体癌症检出性能有前景。

要点

  • AI评分10分(阈值1)检出86.8%筛查检出癌和44.9%间期癌。
  • 阈值3下选中80.1%筛查检出癌和30.7%间期癌。
  • 三个阈值未选中的筛查检出癌比例均低于20%。

核心结论

  • AI系统在三个评估阈值下未选中的筛查检出癌比例均低于20%,总体癌症检出性能有前景。
  • 未被阈值选中的筛查检出癌病理特征较选中者更良好,间期癌则相反。

研究设计与样本

  • 回顾性研究,纳入BreastScreen Norway四个筛查单元2009年10月至2018年12月的122969次筛查检查(47877名女性)。
  • 数据集包括752例筛查检出癌(6.1/1000次检查)和205例间期癌(1.7/1000次检查)。
  • 比较商用AI系统与常规独立双读加共识的性能,AI评分1至10分(1分低风险,10分高风险)。

诊断标准与关键数值

  • 阈值1设为AI评分10分;阈值2设为选择率与共识率(8.8%)相似;阈值3设为选择率与平均单个放射科医师(5.8%)相似。
  • 阈值1下86.8%(653/752)筛查检出癌和44.9%(92/205)间期癌获AI评分10分。
  • 阈值3下80.1%(602/752)筛查检出癌和30.7%(63/205)间期癌被选中。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background Artificial intelligence (AI) has shown promising results for cancer detection with mammographic screening. However, evidence related to the use of AI in real screening settings remain sparse. Purpose To compare the performance of a commercially available AI system with routine, independent double reading with consensus as performed in a population-based screening program. Furthermore, the histopathologic characteristics of tumors with different AI scores were explored. Materials and Methods In this retrospective study, 122 969 screening examinations from 47 877 women performed at four screening units in BreastScreen Norway from October 2009 to December 2018 were included. The data set included 752 screen-detected cancers (6.1 per 1000 examinations) and 205 interval cancers (1.7 per 1000 examinations). Each examination had an AI score between 1 and 10, where 1 indicated low risk of breast cancer and 10 indicated high risk. Threshold 1, threshold 2, and threshold 3 were used to assess the performance of the AI system as a binary decision tool (selected vs not selected). Threshold 1 was set at an AI score of 10, threshold 2 was set to yield a selection rate similar to the consensus rate (8.8%), and threshold 3 was set to yield a selection rate similar to an average individual radiologist (5.8%). Descriptive statistics were used to summarize screening outcomes. Results A total of 653 of 752 screen-detected cancers (86.8%) and 92 of 205 interval cancers (44.9%) were given a score of 10 by the AI system (threshold 1). Using threshold 3, 80.1% of the screen-detected cancers (602 of 752) and 30.7% of the interval cancers (63 of 205) were selected. Screen-detected cancer with AI scores not selected using the thresholds had favorable histopathologic characteristics compared to those selected; opposite results were observed for interval cancer. Conclusion The proportion of screen-detected cancers not selected by the artificial intelligence (AI) system at the three evaluated thresholds was less than 20%. The overall performance of the AI system was promising according to cancer detection. © RSNA, 2022.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Larsen, Aglen, Lee, et al. Artificial Intelligence Evaluation of 122 969 Mammography Examinations from a Population-based Screening Program. Radiology. 2022. PMID: 35348377. doi:10.1148/radiol.212381

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。